Fortitude Family Office, LLC Iovance Biotherapeutics, Inc. Transaction History
Fortitude Family Office, LLC
- $305 Billion
- Q2 2025
A detailed history of Fortitude Family Office, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 142 shares of IOVA stock, worth $332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142Holding current value
$332% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
327Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$65 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$57.1 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$49.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$29.7 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$25.8 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $369M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...